GlassScriptPhysician profile
Allison L Soward
NPI 1891942173
$1,438.13
in general payments reported to CMS, 2019-2025
30 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.42 · 2022: $200 · 2023: $409 · 2024: $452 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.74 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $169.12 | 2024-2025 | Nanoknife |
| Takeda Pharmaceuticals U.S.A., INC. | $119.38 | 2022-2024 | Gattex |
| Ethicon US, LLC | $108.60 | 2023 | Echelon Flex |
| Merck Sharp & Dohme LLC | $101.97 | 2023-2025 | Keytruda, Lynparza |
| Intuitive Surgical, INC. | $100.94 | 2022 | |
| Boston Scientific Corporation | $95.69 | 2024 | Rezum Generator |
| Csl Behring | $64.67 | 2023-2024 | Kcentra |
| Vertex Pharmaceuticals Incorporated | $53.01 | 2024-2025 | |
| Abbvie INC. | $51.97 | 2023 | |
| Teleflex LLC | $51.80 | 2024-2025 | Urolift, Barrigel |
| Smith+Nephew, INC. | $48.48 | 2025 | Stravix Pl |
| Dilon Technologies, INC. | $46.67 | 2023 | Hemoblast Bellows |
| Trevena, INC. | $38.57 | 2023 | Olinvyk |
| Davol INC. | $36.31 | 2022-2025 | Arista |
| Procept Biorobotics Corporation | $30.86 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.07 | 2022 | |
| Olympus America INC. | $29.93 | 2023 | Itind System, Soltive |
| Lemaitre Vascular, INC. | $29.90 | 2024 | Artegraft Vascular Graft |
| Dendreon Pharmaceuticals LLC | $28.21 | 2024 | Provenge |
| Sumitomo Pharma America, INC. | $25.89 | 2025 | Gemtesa |
| Laborie Medical Technologies Corp. | $23.74 | 2025 | |
| Novo Nordisk INC | $21.56 | 2023 | Ozempic, Rybelsus |
| Abc Home Medical Supply, INC. | $21.23 | 2024 | |
| Myriad Genetic Laboratories, INC. | $17.36 | 2024 | Prolaris |
| Northgate Technologies, INC. | $17.06 | 2023 | Nti Branded Other (Nti) |
| Civco Medical Instruments | $16.12 | 2025 | |
| Conmed Corporation | $15.86 | 2024 | Airseal |
| Astellas Pharma US INC | $15.28 | 2021 | |
| Antares Pharma, INC. | $14.70 | 2025 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Soward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.